Skip to contentHome page Seeking Alpha - Power to InvestorsTranscriptsApr 14, 2026, 4:51 PM ETHarmony Biosciences Holdings, Inc. (HRMY) StockSA Transcripts159.3K FollowersCommentsHarmony Biosciences Holdings, Inc. (HRMY) 25th Annual Needham Virtual Healthcare Conference April 13, 2026 9:30 AM EDTCompany ParticipantsJeffrey Dayno - President, CEO & DirectorAdam Zaeske - Executive VP & Chief Commercial OfficerKumar Budur - Executive VP and Chief Medical & Scientific OfficerConference Call ParticipantsAmi Fadia - Needham & Company, LLC, Research DivisionPresentationAmi FadiaNeedham & Company, LLC, Research DivisionGood morning, everyone. I'm Ami Fadia, biotech analyst here at Needham. It's my pleasure to be hosting the Harmony Bioscience team today. I have with me Jeff Dayno, who's the CEO of the company; along with Kumar Budur, Chief Scientific Officer; and Adam Zaeske, Chief Commercial Officer. Thanks, all 3 of you for taking the time to be with us today.Question-and-Answer SessionAmi FadiaNeedham & Company, LLC, Research DivisionMaybe if I could ask Jeff, if you could kick us off with some opening remarks, some priorities for this year, and then we can take it from there?Jeffrey DaynoPresident, CEO & DirectorYes. Sure, Ami. Yes, Ami. And on behalf of the Harmony team, thank you once again for the invitation to Needham's Virtual Healthcare Conference. And we are very excited for what is coming this year, that sets us up for both near-term and long-term growth and value creation. As for some of our key priorities, just to sort of walk through, starting with WAKIX. So we are on track to achieve over $1 billion in net revenue for WAKIX in its sixth year on the market, which provides us with a very solid foundation, I think, as many are aware.In our pitolisant next-gen programs, pitolisant GR gastro-resistant is on track for NDA submission this quarter to extend the pitolisant franchise with a target PDUFA date in the firstRead more current HRMY analysis and newsView all earnings call transcriptsCommentsTo ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.Is this happening to you frequently? Please report it on our feedback forum.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.